Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis-Reference-Cited by-同舟云学术

Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis

Published:2002-10-02 Issue:2 Volume:83 Page:412-420
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Delobel Patrice,Flament Stéphane,Hamdane Malika,Mailliot Christel,Sambo Anne-Véronique,Bégard Séverine,Sergeant Nicolas,Delacourte André,Vilain Jean-Pierre,Buée Luc

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1471-4159.2002.01143.x/fullpdf

Reference37 articles.

1. Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death;Arendt;Ann. NY Acad. Sci.,2000

2. Purification of a 15-kDa cdk4- and cdk5-binding protein;Azzi;J. Biol. Chem.,1994

3. Activation of Xenopus eggs by the kinase inhibitor 6-DMAP suggests a differential regulation of cyclin B and p39 (mos) proteolysis;Bodart;Exp. Cell Res.,1999

4. Sequential dephosphorylation of p34 (cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition;Borgne;J. Biol. Chem.,1996

5. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders;Buée;Brain Res. Rev.,2000

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herpes Simplex Virus Type 1 Induces AD-like Neurodegeneration Markers in Human Progenitor and Differentiated ReNcell VM Cells;Microorganisms;2023-05-04

2. Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: Possible implication for Alzheimer’s disease;Progress in Neurobiology;2023-04

3. The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer’s disease;Biomedicine & Pharmacotherapy;2022-07

4. Aetiology and pathophysiology of neurodegenerative disorders;Nanomedical Drug Delivery for Neurodegenerative Diseases;2022

5. Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target;Frontiers in Neurology;2020-11-12